Proteomic and Genetic Insights into Ancestry‐Specific Associations in Parkinson's Disease
Movement Disorders · 2026
DOI: 10.1002/mds.70169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Amanda Wei-Yin Lim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Program, QIMR Berghofer, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: East Asian People, European People, Parkinson Disease, Proteomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
Although genome‐wide association studies (GWAS) have identified numerous common genetic risk variants for Parkinson's disease (PD), the underlying biological mechanisms remain largely unresolved.
Objectives
We aimed to identify circulating proteins causally associated with PD risk in European and East Asian populations and determine whether these associations are shared or ancestry‐specific.
Methods
We employed a two‐sample Mendelian randomization (MR) approach, integrating large‐scale proteomic and genetic data, with validation using summary‐data‐based MR (SMR). European analyses used UK Biobank Pharma Proteomics Project (UKB‐PPP; n = 54,219; 2,392 proteins) and a large PD GWAS (37,688 cases, 18,618 proxy cases, 1.4 million controls). East Asian analyses combined Han Chinese and UKB‐PPP data (n = 3,220; 229 proteins) with a PD GWAS (6,724 cases, 24,851 controls). False discovery rate (FDR) < 0.05 determined significance. Sensitivity analyses addressed instrument heterogeneity, pleiotropy, and sample overlap.
Results
MR analyses identified 21 proteins causally associated with PD in Europeans and 8 in East Asians, all directionally concordant in SMR validation. Notably, BST1 emerged as a shared causal protein, increasing PD risk in both Europeans (odds ratio [OR] = 1.04, 95% confidence interval [CI]: 1.02–1.06) and East Asians (OR = 1.18, 95% CI: 1.10–1.27), remaining robust after excluding UK Biobank participants. Several ancestry‐specific proteins were detected, including TXNDC15 in Europeans and PM20D1 in East Asians, both targets of existing or investigational drugs.
Conclusions
This cross‐ancestry proteogenomic analysis reveals shared and ancestry‐specific proteomic signatures causally linked to PD, underscoring the importance of using ancestry‐aware analytical frameworks to discover robust biomarkers and novel therapeutic targets. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Population Health Program, QIMR Berghofer, Brisbane, QLD, Australia.
- Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
- Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore.
- Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- The Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, University of Malaya, Kuala Lumpur, Malaysia.
ORCID-Profile: Amanda Wei-Yin Lim, Ai Huey Tan
Zitieren
APA
Lim, A. W., Foo, J. N., Chew, E. G., Lim, S. Y., Tan, A. H., Hwang, L. D., MacGregor, S., Rentería, M. E., & Ong, J. S. (2026). Proteomic and Genetic Insights into Ancestry‐Specific Associations in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70169
Vancouver
Lim AW, Foo JN, Chew EG, Lim SY, Tan AH, Hwang LD, et al. Proteomic and Genetic Insights into Ancestry‐Specific Associations in Parkinson's Disease. Movement Disorders. 2026. doi:10.1002/mds.70169
BibTeX
@article{Lim2026,
author = {Lim, Amanda Wei-Yin and Foo, Jia-Nee and Chew, Elaine Guo-Yan and Lim, Shen-Yang and Tan, Ai Huey and Hwang, Liang-Dar and MacGregor, Stuart and Rentería, Miguel E and Ong, Jue-Sheng},
title = {Proteomic and Genetic Insights into Ancestry‐Specific Associations in Parkinson's Disease},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70169}
}
EUVIMED